| Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study O Santos-Morales, A Díaz-Machado, D Jiménez-Rodríguez, ... BMC neurology 17, 1-9, 2017 | 46 | 2017 |
| Erythropoietin in Spinocerebellar ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study R Rodriguez‐Labrada, R Ortega‐Sanchez, P Hernandez Casana, ... Movement Disorders 37 (7), 1516-1525, 2022 | 15 | 2022 |
| The position of EGF deprivation in the management of advanced Non-Small Cell Lung Cancer T Crombet Ramos, O Santos Morales, GK Dy, K León Monzón, ... Frontiers in Oncology 11, 639745, 2021 | 12 | 2021 |
| Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC R Evans, K Lee, PK Wallace, M Reid, J Muhitch, A Dozier, C Mesa, ... Frontiers in Oncology 12, 958043, 2022 | 5 | 2022 |
| Utilización de antipsicóticos en el Hospital Psiquiátrico de La Habana durante los años 2006 y 2007 O Santos, Y Pérez, M Bourín Rev Hosp Psiquiátrico de La Habana [Internet] 6 (1), 2009 | 5 | 2009 |
| Final results from a phase II trial of CIMAvax-EGF and nivolumab as second-line (2L) therapy after platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC). R Frascati, AP Early, ME Reid, K Lee, J Muhitch, C Mesa, PL Luaces, ... Journal of Clinical Oncology 41 (16_suppl), 9135-9135, 2023 | 2 | 2023 |
| Abstract CT130: Evidence for synergistic immune responses in the first-in-human (FIH) combination of B cell-activating immunotherapy (IO) with anti-PD1 immune checkpoint … T Crombet, J Muhitch, C Mesa, R Evans, DS Hernandez, PL Luaces, ... Cancer Research 80 (16_Supplement), CT130-CT130, 2020 | 2 | 2020 |
| Mecanismo de acción comparado de los diferentes antipsicóticos O Santos, M Bourin Rev. Hosp. Psiquiátrico de la Habana 2 (2), 2, 2005 | 2 | 2005 |
| High levels of serum EGF concentration predict response to CIMAvax-EGF treatment in advanced NSCLC O Santos Morales, L Luaces, E Neninger, T Crombet Journal of Cancer Science and Clinical Therapeutics 5 (1), 1-10, 2021 | 1 | 2021 |
| Analisis cuantitativo y cualitativo de la produccion de manzanas de las comunas de Mariquina y Mafil (provincia de Valdivia). CJL Troncoso, S Gonzalez, O Morales, H Castillo, L Postius, JL Pizarro | 1 | 1974 |
| Abstract CT126: A Phase 0 Study of EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS-and BRAF Wild-Type Metastatic Colorectal Cancer D Vadehra, C Janes, R Frascati, M Reid, TC Ramos, S Mukherjee, ... Cancer Research 84 (7_Supplement), CT126-CT126, 2024 | | 2024 |
| Safety and effectiveness of CIMAvax-EGF administered in community polyclinics RA Ortiz Carrodeguas, G Lorenzo Monteagudo, PP Guerra Chaviano, ... Frontiers in Oncology 13, 1287902, 2024 | | 2024 |
| Use of epidermal growth factor depleting agents in the treatment of chronic obstructive pulmonary disease AEM Abraham, TC Ramos, KL Monzón, DS Hernández, OS Morales, ... US Patent App. 18/018,156, 2023 | | 2023 |
| Immune Deprivation of Growth Factors as Cancer Therapy T Crombet Ramos, Y Morera Díaz, E Neninger Vinageras, ... Handbook of Cancer and Immunology, 1-23, 2023 | | 2023 |
| P2. 01-33 Survival Benefit of Depleting High Serum EGF Concentration in Advanced NSCLC Patients as Switch Maintenance Therapy OS Morales, E Neninger, R Carrodeguas, P Luaces, P Rodríguez, ... Journal of Thoracic Oncology 14 (10), S651-S652, 2019 | | 2019 |
| P1. 01-84 High Basal Serum EGF Levels Predicts Response to CIMAvax-EGF, a Therapeutic Vaccine for Advanced NSCLC OS Morales, P Luaces, T Crombet, C Rodríguez, E Neninger Journal of Thoracic Oncology 13 (10), S495, 2018 | | 2018 |
| Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: A O Santos-Morales, A Díaz-Machado, D Jiménez-Rodríguez, ... Neurotox Res 20 (2), 182-92, 2011 | | 2011 |
| Tratamiento psicofarmacológico del trastorno bipolar: Una revisión necesaria. OS Morales, YP Rodríguez, M Bourin Rev. Hosp. Psiquiátrico de la Habana 7 (2), 2010 | | 2010 |
| DROGAS RECIENTEMENTE DESARROLLADAS EN EL TRATAMIENTO DE LA DEPRESIÓN UNIPOLAR OS Morales, M Bourin, IN Gonzalez Rev. Hosp. Psiquiátrico de la Habana 5 (3), 3, 2008 | | 2008 |
| Predictors of global cognitive functioning in drug addicted patients O Santos, JC Penalver, M Bourin INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 9, S172-S173, 2006 | | 2006 |
Tania Crombet Ramos, MD, PhDClinical Research Director, Center of Molecular Immunology, Havana, CubaVerified email at cim.sld.cu
